Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells

Nature Genetics

Volumn 37, Issue 11, 2005, Pages 1264-1269

  Ohgami, Robert S ^a   Campagna, Dean R ^a   Greer, Eric L ^a   Antiochos, Brendan ^a   McDonald, Alice ^b   Chen, Jing ^c,f   Sharp, John J ^d,f,g   Fujiwara, Yuko ^e   Barker, Jane E ^d   Fleming, Mark D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d JACKSON LABORATORY   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f EMORY UNIVERSITY   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVINE ADENINE NUCLEOTIDE; IRON; IRON REDUCTASE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; ENDOSOME; ENZYME ACTIVITY; ENZYME ANALYSIS; ERYTHROID CELL; EVOLUTIONARY HOMOLOGY; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; HEMATOPOIETIC TISSUE; HUMAN; HUMAN CELL; IRON DEFICIENCY ANEMIA; IRON TRANSPORT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIX TRANSMEMBRANE EPITHELIAL ANTIGEN OF THE PROSTATE 3; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANEMIA, IRON-DEFICIENCY; ANIMALS; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELLS, CULTURED; ENDOSOMES; ERYTHROCYTES; FEMALE; FMN REDUCTASE; GENE TARGETING; IRON; KIDNEY; MALE; MICE; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; RETROVIRIDAE; SEQUENCE HOMOLOGY, AMINO ACID; SUBCELLULAR FRACTIONS; TRANSFERRIN;

ANIMALIA;

EID: 27644455133     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1658     Document Type: Article

References (30)

1. Ponka, P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89, 1-25 (1997).
2. Fleming, M.D. et al. Microcytic anemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16, 383-386 (1997).
3. Fleming, M.D. et al. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc. Natl. Acad. Sci. USA 95, 1148-1153 (1998).
4. Gunshin, H. et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488 (1997).
5. McKie, A.T. et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291, 1755-1759 (2001).
6. Gunshin, H.S. et al. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood, published online 16 June 2005 (doi:10.1182/blood-2005-02-0716).
7. Inman, R.S., Coughlan, M.M. & Wessling-Resnick, M. Extracellular ferrireductase activity of K562 cells is coupled to transferrin-independent iron transport. Biochemistry 33, 11850-11857 (1994).
8. Nunez, M-T., Gaete, V., Watkins, J.A. & Glass, J. Mobilization of iron from endocytic vesicles. The effects of acidification and reduction. J. Biol. Chem. 265, 6688-6692 (1990).
9. Dhungana, S. et al. Redox properties of human transferrin bound to its receptor. Biochemistry 43, 205-209 (2004).
10. Ohgami, R.S. et al. nm1054, a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. Blood, published online 30 June 2005 (doi:10.1182/blood-2005-01-0379).
11. Porkka, K.P., Nupponen, N.N., Tammela, T.L., Vessella, R.L. & Visakorpi, T. Human pHyde is not a classical tumor suppressor gene in prostate cancer. Int. J. Cancer 106, 729-735 (2003).
12. Steiner, M.S., Zhang, X., Wang, Y. & Lu, Y. Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde. Cancer Res. 60, 4419-4425 (2000).
13. Zhang, X., Steiner, M.S., Rinaldy, A. & Lu, Y. Apoptosis induction in prostate cancer cells by a novel gene product, pHyde, involves caspase-3. Oncogene 20, 5982-5990 (2001).
14. Amzallag, N. et al. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. J. Biol. Chem. 279, 46104-46112 (2004).
15. Passer, B.J. et al. The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proc. Natl. Acad. Sci. USA 100, 2284-2289 (2003).
16. Labbe, R., Vreman, H. & Stevenson, D. Zinc protoporhyrin: A metabolite with a mission. Clin. Chem. 45, 2060-2072 (1999).
17. Bateman, A. et al. The Pfam protein families database. Nucleic Acids Res. 32, D138-D141 (2004).
18. Sanchez-Pulido, L., Rojas, A.M., Valencia, A., Martinez, A.C. & Andrade, M.A. ACRATA: a novel electron transfer domain associated to apoptosis and cancer. BMC Cancer 4, 98 (2004).
19. Warkentin, E. et al. Structures of F420H2:NADP+ oxidoreductase with and without its substrates bound. EMBO J. 20, 6561-6569 (2001).
20. Moldes, M. et al. Tumor necrosis factor-alpha-induced adipose-related protein (TIARP), a cell-surface protein that is highly induced by tumor necrosis factor-alpha and adipose conversion. J. Biol. Chem. 276, 33938-33946 (2001).
21. Porkka, K.P., Helenius, M.A. & Visakorpi, T. Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate. Lab. Invest. 82, 1573-1582 (2002).
22. Shatwell, K.P., Dancis, A., Cross, A.R., Klausner, R.D. & Segal, A.W. The FRE1 ferric reductase of Saccharomyces cerevisiae is a cytochrome b similar to that of NADPH oxidase. J. Biol. Chem. 271, 14240-14244 (1996).
23. Finegold, A.A., Shatwell, K.P., Segal, A.W., Klausner, R.D. & Dancis, A. Intramembrane bis-heme motif for transmembrane electron transport conserved in a yeast iron reductase and the human NADPH oxidase. J. Biol. Chem. 271, 31021-31024 (1996).
24. Hubert, R.S. et al. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc. Natl. Acad. Sci. USA 96, 14523-14528 (1999).
25. Yang, D., Holt, G.E., Velders, M.P., Kwon, E.D. & Kast, W.M. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice. Cancer Res. 61, 5857-5860 (2001).
26. Goldman, G.L. & Thornton, J.I. A new trace ferrous metal detection reagent. J. Forensic Sci. 21, 625-628 (1976).
27. Lesuisse, E., Casteras-Simon, M. & Labbe, P. Evidence for the Saccharomyces cerevisiae ferrireductase system being a multicomponent electron transport chain. J. Biol. Chem. 271, 13578-13583 (1996).
28. Ross, J.S. et al. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin. Cancer Res. 9, 6357-6362 (2003).
29. Su, M.A., Trenor, C.C., Fleming, J.C., Fleming, M.D. & Andrews, N.C. The G185R mutation disrupts function of iron transporter Nramp2. Blood 92, 2157-2163 (1998).
30. Schwaller, J. et al. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J. 17, 5321-5333 (1998).